Researchers at Washington University School of Medicine are joining scientists around the country to conduct a study aimed at understanding how prenatal factors and early life experiences influence brain development and behavior in young children.
Researchers at Washington University School of Medicine have found that multidrug-resistant bacteria and bacterial spores can be killed by ultrashort-pulse lasers. The findings could lead to new ways to sterilize wounds and blood products without damaging human cells.
Trail cameras have captured 567 pictures of local turkeys as part of the St. Louis Wildlife Project, an effort led by scientists at Tyson Research Center and the University of Health Sciences and Pharmacy in St. Louis.
Despite others’ previous claims, the lab of Yevgeniy Vorobeychik and collaborators have determined it’s not so easy for a neural network to recreate a person’s face from DNA.
Brian Kim, MD, at the School of Medicine, received a five-year, $2.4 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) to research skin inflammation.
A team of researchers led by Song Hu at the McKelvey School of Engineering has developed a two-step denoising technique for photoacoustic microscopy, a method that allows researchers to see tiny vessels in the body.
Research from the lab of Renee J. Thompson in Arts & Sciences shows social media use associated with mixed outcomes when it comes to well-being during the pandemic.
Washington University in St. Louis senior Kennedy Young was a finalist for the prestigious Rhodes Scholarship. She has devoted her years at Washington University to studying the history of mass incarceration and working directly with those in the prison system today.
Researchers at Washington University are receiving one of 19 grant awards that will support data science research and training activities in Africa. The researchers will focus on developing new training programs in health data science in Rwanda.
People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer’s COVID-19 vaccine, according to a study from Washington University School of Medicine.
View More Stories